The Combination of Low-Frequency Ultrasound and Antibiotics Improves the Killing of In Vitro Staphylococcus aureus and Pseudomonas aeruginosa Biofilms. 2022

Lasse Kvich, and Mads H Christensen, and Malgorzata K Pierchala, and Konstantin Astafiev, and Rasmus Lou-Moeller, and Thomas Bjarnsholt
Costerton Biofilm Center, Department of Immunology and Microbiology, University of Copenhagen, DK-2200 Copenhagen, Denmark.

Due to an increase in underlying predisposing factors, chronic wounds have become an increasing burden on healthcare systems worldwide. Chronic infections often contain biofilm-forming bacteria, which are challenging to eradicate due to increased antibiotic tolerance; thus, new and improved therapeutic strategies are warranted. One such strategy is the combination of ultrasound and antibiotics. Therefore, this study aimed to investigate the combinatory effects of low-frequency (50 kHz) ultrasound delivered by specially designed ultrasound patches using flexible piezoelectric material, PiezoPaint™, in combination with antibiotics against biofilms with Staphylococcus aureus and Pseudomonas aeruginosa. The reduction in viable cells in S. aureus and P. aeruginosa biofilms was evaluated post-treatment with fusidic acid, clindamycin, ciprofloxacin, and colistin in combination with ultrasound treatment. Two-hour ultrasound treatment significantly increased the bactericidal effect of all four antibiotics, resulting in a 96−98% and 90−93% reduction in P. aeruginosa and S. aureus, respectively. In addition, an additive effect was observed when extending treatment to 4 h, resulting in >99% and 95−97% reduction in P. aeruginosa and S. aureus, respectively. These results contrasted the lack of effect observed when treating filter-biofilms with antibiotics alone. The combined effect of ultrasound and antibiotic treatment resulted in a synergistic effect, reducing the viability of the clinically relevant pathogens S. aureus and P. aeruginosa. The modularity of the specially designed patches intended for topical treatment holds promising applications as a supplement in chronic wound therapy. Further studies are warranted with clinically isolated strains and other clinically relevant antibiotics before proceeding to studies where safety and applicability are investigated.

UI MeSH Term Description Entries

Related Publications

Lasse Kvich, and Mads H Christensen, and Malgorzata K Pierchala, and Konstantin Astafiev, and Rasmus Lou-Moeller, and Thomas Bjarnsholt
December 2008, Langmuir : the ACS journal of surfaces and colloids,
Lasse Kvich, and Mads H Christensen, and Malgorzata K Pierchala, and Konstantin Astafiev, and Rasmus Lou-Moeller, and Thomas Bjarnsholt
January 2020, Experimental biology and medicine (Maywood, N.J.),
Lasse Kvich, and Mads H Christensen, and Malgorzata K Pierchala, and Konstantin Astafiev, and Rasmus Lou-Moeller, and Thomas Bjarnsholt
August 2020, ChemMedChem,
Lasse Kvich, and Mads H Christensen, and Malgorzata K Pierchala, and Konstantin Astafiev, and Rasmus Lou-Moeller, and Thomas Bjarnsholt
December 2015, Colloids and surfaces. B, Biointerfaces,
Lasse Kvich, and Mads H Christensen, and Malgorzata K Pierchala, and Konstantin Astafiev, and Rasmus Lou-Moeller, and Thomas Bjarnsholt
August 2002, The Japanese journal of antibiotics,
Lasse Kvich, and Mads H Christensen, and Malgorzata K Pierchala, and Konstantin Astafiev, and Rasmus Lou-Moeller, and Thomas Bjarnsholt
July 2009, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery,
Lasse Kvich, and Mads H Christensen, and Malgorzata K Pierchala, and Konstantin Astafiev, and Rasmus Lou-Moeller, and Thomas Bjarnsholt
January 2017, PloS one,
Lasse Kvich, and Mads H Christensen, and Malgorzata K Pierchala, and Konstantin Astafiev, and Rasmus Lou-Moeller, and Thomas Bjarnsholt
January 1987, The Journal of antimicrobial chemotherapy,
Lasse Kvich, and Mads H Christensen, and Malgorzata K Pierchala, and Konstantin Astafiev, and Rasmus Lou-Moeller, and Thomas Bjarnsholt
June 2009, International journal of antimicrobial agents,
Lasse Kvich, and Mads H Christensen, and Malgorzata K Pierchala, and Konstantin Astafiev, and Rasmus Lou-Moeller, and Thomas Bjarnsholt
March 2020, Journal of bacteriology,
Copied contents to your clipboard!